WOONSOCKET, R.I., Dec. 28, 2011 /PRNewswire/ -- CVS Caremark Corporation (NYSE: CVS) today announced that Larry Merlo, the company's president and chief operating officer, will be making a presentation to investors at the J.P. Morgan Healthcare Conference on January 10, 2012. Mr. Merlo is scheduled to present at 7:30 am local time (10:30 am EST).
An audio webcast of the presentation will be broadcast simultaneously through the Investor Relations portion of the CVS Caremark website for all interested parties. To access the webcast, visit http://info.cvscaremark.com/investors. This webcast will be archived and available on the website for a one-year period following the presentation.
About CVS Caremark
CVS Caremark is the largest pharmacy health care provider in the United States with integrated offerings across the entire spectrum of pharmacy care. We are a pharmacy innovation company, uniquely positioned to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of more than 65,000 pharmacies, including more than 7,300 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical offerings include our signature Pharmacy Advisor™ program as well as innovative generic step therapy and genetic benefit management programs that promote more cost effective and healthier behaviors and improve health care outcomes. General information about CVS Caremark is available through the Company's website at http://info.cvscaremark.com/.
SOURCE CVS Caremark Corporation
Investors: Nancy Christal, Senior Vice President, Investor Relations, +1-914-722-4704, or Media: Eileen Howard Boone, Senior Vice President, Corporate Communications & Community Relations, +1-401-770-4561